Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

por Schrama, J G, Holtkamp, M J, Baars, J W, Schornagel, J H, Rodenhuis, S
Publicado 2003

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

por van der Wall, E., Rutgers, E. J., Holtkamp, M. J., Baars, J. W., Schornagel, J. H., Peterse, J. L., Beijnen, J. H., Rodenhuis, S.
Publicado 1996

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

por van der Wall, E., Nooijen, W. J., Baars, J. W., Holtkamp, M. J., Schorangel, J. H., Richel, D. J., Rutgers, E. J., Slaper-Cortenbach, I. C., van der Schoot, C. E., Rodenhuis, S.
Publicado 1995